Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500112657Phase 4Not yet recruiting
Phase 4, randomised trial of propofol, ciprofol, remimazolam, sufentanil, esketamine and 1 more in postoperative fatigue (9 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Postoperative fatigue. Planned start Nov 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500112657.